Key Quantitative Figures

  • Number of equity shares allotted: 203,259
  • Face value per share: ₹1
  • Number of employees who exercised options: 77
  • New issued, subscribed and paid-up share capital: ₹164,959,682
  • Total number of equity shares outstanding: 164,959,682
  • Distinctive numbers of allotted shares: 16,47,56,424 to 16,49,59,682 (both inclusive)

Parties Involved

  • Approving authority: ESOP Compensation Committee of the Board of Directors
  • Recipients: 77 employees of the company
  • Regulatory references: SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Regulation 30); SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (Regulation 10(c))

Scheme Details

  • Scheme name: Gland Pharma Employee Stock Options Scheme, 2025
  • Previous filing numbers: BSE - 231155; NSE - 48425
  • Shares issued in dematerialized form
  • Share certificate numbers: Not applicable

Capital Structure Impact

The allotment has increased the company's issued, subscribed and paid-up share capital to ₹164,959,682 comprising 164,959,682 equity shares of face value ₹1 each.